CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group
Summary
All 20 smoldering myeloma patients had deep responses after one-time infusion
Description
All 20 smoldering myeloma patients had deep responses after one-time infusion
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source